ZimVie (NASDAQ:ZIMV) Issues Quarterly Earnings Results

ZimVie (NASDAQ:ZIMV) issued its quarterly earnings data on Wednesday. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02, Zacks reports. The business had revenue of $111.52 million during the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. ZimVie updated its FY 2025 guidance to 0.800-0.950 EPS.

ZimVie Price Performance

NASDAQ:ZIMV traded down $0.75 during midday trading on Thursday, hitting $12.36. 68,397 shares of the stock were exchanged, compared to its average volume of 248,449. The business has a 50-day moving average price of $13.77 and a two-hundred day moving average price of $14.79. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $340.99 million, a price-to-earnings ratio of -0.94 and a beta of 2.10. ZimVie has a one year low of $12.26 and a one year high of $22.40.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reissued a “buy” rating and set a $23.00 price target on shares of ZimVie in a report on Thursday.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.